Leukocyte concentration, red cell concentration, plasma for transfusion, and platelet concentration, are some of the blood products, which are obtained from the processing of single donations of blood or plasma. In whole blood, red blood cells, leukocytes, and platelets are suspended within the plasma. Blood plasma is the liquid component of the whole blood, and makes up approximately 55% of the total blood volume.

1. Plasma Fraction Market: Global Industry Analysis and Forecast 2014 - 2020
Persistence Market Research
Plasma Fraction Market: Global Industry
Analysis and Forecast 2014 - 2020
Persistence Market Research 1

2. Plasma Fraction Market: Global Industry Analysis and Forecast 2014 - 2020
Persistence Market Research Released New Market Report on “Plasma Fraction Market:
Global Industry Analysis and Forecast 2014 - 2020”.
Leukocyte concentration, red cell concentration, plasma for transfusion, and platelet concentration, are
some of the blood products, which are obtained from the processing of single donations of blood or
plasma. In whole blood, red blood cells, leukocytes, and platelets are suspended within the plasma. Blood
plasma is the liquid component of the whole blood, and makes up approximately 55% of the total blood
volume. It is a complex biological material mainly composed of water with small amount of minerals, ions,
nutrients, salts, and proteins in the solution. Human plasma is composed of protease inhibitors, protease,
fibrinolytic proteins, coagulation factors, and anti-coagulant proteins. Human plasma is obtained through
large scale processing steps known as fractionation, i.e. a sequence of process in which plasma is
separated for medicinal use. Human blood plasma is obtained by separating the plasma from the whole
blood or by apheresis.
Buy Full Report: http://www.persistencemarketresearch.com/market-research/plasma-fraction-
market.asp
Differential solubility of proteins, differential interaction of protein with solid media and interaction with
physical field are various methods for plasma fraction. Human plasma for fractionation is the starting
material for the manufacture of a range of medicinal products used for the treatment of a variety of life-
threatening injuries and diseases such as immunological disorders, infections, trauma, and congenital
deficiencies. In addition, with extensive measures to eliminate infectious donations along with various
steps to eliminate and inactivate contaminated virus has reduced the risk of disease transmission by
plasma products. Technological innovation and production methods of plasma fractionation are helping to
extensively improve product purity, and the yields of plasma-derived proteins in plasma fractionation.
North America dominates the global market for plasma fraction due to rise in neurological and
autoimmune disorders, and increasing geriatric population in the region. Asia is expected to show high
growth rates in the next five years in the global plasma fraction market, with China and India being the
fastest-growing markets in the Asia Pacific region. The key driving forces for the plasma fraction market in
developing countries are the large pool of patients, increasing awareness about the disease, increasing
disposable income, rising number of hemophilic patients, increasing organ transplantation, increasing use
of immunoglobulins, and rising government funding in the region.
Persistence Market Research 2

3. Plasma Fraction Market: Global Industry Analysis and Forecast 2014 - 2020
Increasing number of hemophilic patients, rise in geriatric population, increase in healthcare awareness
and expenditure, growing off-label use of albumin and immunoglobulin in various chronic diseases,
increased diagnosis rate of diseases, rise in the use of prophylactic treatment for bleeding and immune
diseases, and increasing disposable income in developing countries are some of the key factors driving
the growth of the global plasma fraction market. However, strict government regulations, high cost and
limited reimbursement, economic slowdown, and rising number of recombinant products act as major
restraints for the growth of the global plasma fraction market.
Some of the major trends in the global plasma fraction market are increasing market consolidation, rising
adoption of subcutaneous Ig ScIg therapy, increasing number of local players, and rising number of
plasma fraction collection centers. The major companies operating in the global plasma fraction market
are Baxter International, Inc., Octapharma AG, Biotest AG, CSL, Ltd., Grifols International S.A., Kedrion
S.p.A., LFB S.A., Chinese Biological Products, Inc., and Shanghai RAAS Blood Products Co., Ltd.
Request Full TOC: http://www.persistencemarketresearch.com/toc/4258
Key points covered in the report:-
1. Report segments the market on the basis of types, application, products, technology, etc
(as applicable)
2. The report covers geographic segmentation
 North America
 Europe
 Asia
 RoW
3. The report provides the market size and forecast for the different segments and
geographies for the period of 2010 to 2020
4. The report provides company profiles of some of the leading companies operating in the
market
5. The report also provides porters five forces analysis of the market.
Browse the full “All Upcoming Persistence Market's ” report at
http://www.persistencemarketresearch.com/forthcoming-reports.asp
About Us:
Persistence Market Research is a global market research firm specializing- syndicated
research, custom research, and consulting services
Persistence Market Research 3

4. Plasma Fraction Market: Global Industry Analysis and Forecast 2014 - 2020
At Persistence Market Research (PMR), we are in the business of accelerating your business.
As a full-service market research firm, we stand committed to bringing more accuracy and
speed to your business decisions. From ready-to-purchase market research reports to
customized global research solutions, our engagement models are highly flexible without
compromising on our deep-seated research values. Briefly stated, our mission is to give you
access to forecasts and trends analyses that put you on the path to profitability.
PMR’s Services Go Beyond Gleaning Data:
Most enterprises believe that IT and databases are enough to make an accurate decision. While
we do not dispute that, consider this: How long does it take to make an accurate and strategic
million-dollar decision? We strive to deliver both even with demanding deadlines.
Facilitating Rapid and Informed Business Decisions
PMR was founded with one goal in mind: to offer enterprises a tangible business advantage by
carefully balancing traditional and modern-day research methodologies.
Contact Us:
Addie Thomes
305 Broadway,
7th Floor,
New York City, NY 10007,
United States.
Phone: +1-646-568-7751
USA/Canada Toll Free Number.
1-800-961-0353
E-mail: Sales@persistencemarketresearch.com
Web : http://www.persistencemarketresearch.com/
Persistence Market Research 4